Company intelligence / Profile preview

Defy Partners

Woodside, California, United States

Ownership: Private
Development stage: Other

Overview

Defy, also known as Defy Partners or Defy Partners Management, is an active early-stage venture capital firm rather than a biotech, pharma, or healthcare operating company. The firm invests across multiple sectors including software, fintech, consumer, AI, and selected healthcare or life sciences opportunities, but it does not itself appear to develop therapeutic products or run a drug pipeline. Public sources describe Defy as a seed-stage or early-stage fund founded by experienced technology investors and based in Woodside, California. For biotech diligence purposes, Defy should be classified as an investor in healthcare and life sciences companies, not as a life sciences developer, CRO, CDMO, or commercial healthcare operator.

Industry: Investors

Beyond the preview

Go deeper on Defy Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Defy Partners.

Explore the full profile